What Arvinas, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 23 |
| Total trades | 0 | 35 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 407,761 |
| Disposed | 0 | 126,256 |
| Net activity | +0 | +281,505 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Saik Andrew | Chief Financial Officer | Jun 24 | Sale for tax withholding · S | −5,696 | $8.16 | −$46.5K | 187,432 |
| Bain Linda | Director | Jun 24 | Grant / award · A | +15,527 | — | — | 41,572 |
| Cunningham Everett | Director | Jun 24 | Grant / award · A | +15,527 | — | — | 41,572 |
| Kennedy Edward Moore Jr. | Director | Jun 24 | Grant / award · A | +15,527 | — | — | 54,957 |
| Morrison Briggs | Director | Jun 24 | Grant / award · A | +15,527 | — | — | 111,548 |
| Norwalk Leslie V | Director | Jun 24 | Grant / award · A | +15,527 | — | — | 41,572 |
| Smaldone Alsup Laurie | Director | Jun 24 | Grant / award · A | +15,527 | — | — | 41,572 |
| Cacace Angela M | Chief Scientific Officer | Jun 17 | Sale for tax withholding · S | −2,576 | $7.60 | −$19.6K | 180,390 |
| Teel Randy | President and CEO | May 21 | Sale for tax withholding · S | −2,209 | $9.04 | −$20K | 285,009 |
| Berkowitz Noah | Chief Medical Officer | May 11 | Sale for tax withholding · S | −11,108 | $9.94 | −$110K | 191,395 |
| Teel Randy | President and CEO | May 11 | Sale for tax withholding · S | −9,657 | $9.94 | −$96K | 287,218 |
| Cacace Angela M | Chief Scientific Officer | May 11 | Sale for tax withholding · S | −9,657 | $9.94 | −$96K | 182,966 |
| Saik Andrew | Chief Financial Officer | May 11 | Sale for tax withholding · S | −11,139 | $9.94 | −$111K | 193,128 |
| Loomis David K | VP, Chief Accounting Officer | May 11 | Sale for tax withholding · S | −1,919 | $9.94 | −$19.1K | 40,193 |
| Berkowitz Noah | Chief Medical Officer | Mar 18 | Sale for tax withholding · S | −6,435 | $11.10 | −$71.4K | 202,503 |
| Morrison Briggs | Director | Mar 06 | Open-market buy · P | +20,000 | $13.40 | +$268K | 96,021 |
| Houston John G | Director | Feb 27 | Sale for tax withholding · S | −11,787 | $13.14 | −$155K | 1,122,183 |
| Houston John G | Director | Feb 27 | Sale for tax withholding · S | −18,822 | $13.24 | −$249K | 1,133,970 |
| Houston John G | Director | Feb 27 | Sale for tax withholding · S | −4,688 | $13.24 | −$62.1K | 1,152,792 |
| Berkowitz Noah | Chief Medical Officer | Feb 26 | Grant / award · A | +45,000 | — | — | 208,938 |
Loading...
